Sign up to receive updates, news, and more.
RockGen is a start-up biotechnology company with innovative goals to develop efficacious treatments for patients suffering from neurodegenerative diseases. We utilize cutting-edge research and investigating the central nervous system to develop novel medicine for Amyotrophic Lateral Sclerosis, Alzheimer’s, Parkinson's and Huntington’s disease.
At RockGen we use proprietary compounds and their evaluations in pre-clinical models of central nervous system diseases. The main goal is to develop efficacious compounds as drugs for testing in clinical trials.
At RockGen we use innovative chemistry to develop pro-drugs and analogs using wet laboratory and in silico systems to expand our pipelines and expedite drug development.